Cover Image
市場調查報告書

南美的醫藥品、醫療產業 (季度更新)

Latin America Pharmaceuticals and Healthcare Report Q4 2016

出版商 BMI Research 商品編碼 362186
出版日期 內容資訊 英文 34 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
南美的醫藥品、醫療產業 (季度更新) Latin America Pharmaceuticals and Healthcare Report Q4 2016
出版日期: 2016年10月26日 內容資訊: 英文 34 Pages
簡介

本報告提供南美的到醫藥品、醫療產業調查分析,到2025年的10年預測為焦點,產業分析,產業預測,產業風險/利潤指數 (RRI) 、市場概要,產業趨勢,各地區的概要等系統性資訊。

BMI的產業分析

SWOT

產業預測

  • 醫藥品市場預測
  • 醫療市場預測

產業風險/利潤指數 (RRI)

  • 南北美洲的RRI

市場概要

產業趨勢與發展

  • 產業趨勢與發展

各地區的概要

詞彙表

調查手法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1032

BMI View: Latin America's pharmaceutical market will continue to be viewed as an important means to expand multinational drugmakers emerging market presence, despite the deteriorating political and economic outlook in the short term. The region's traditional commitment to healthcare, expanding public provision of medical services and the expanding middle class mean that over the long term, there will be significant commercial opportunities for patented and generic drugmakers to exploit.

Headline Expenditure Projections

  • Pharmaceuticals: USD62.6bn in 2015 to USD56.2bn in 2016; -10.3% in US dollar terms.
  • Healthcare: USD372.2bn in 2015 to USD353.7bn in 2016; -5.0% in US dollar terms.

Table of Contents

BMI Industry View

  • Latin America - Q4 2016
    • Table: Headline Pharmaceuticals & Healthcare Forecasts (Latin America (Region) (2014-2020))

SWOT

  • Latin America - Q4 2016

Industry Forecast

  • Pharmaceutical - Latin America - Q4 2016
    • Table: Regional Pharmaceuticals Sales, Historical Data & Forecasts (2014-2020)
  • Healthcare - Latin America - Q4 2016
    • Table: Regional Healthcare Sales, Historical Data & Forecasts (2012-2020)

Industry Risk/Reward Index

  • Americas Risk/Reward Index

Market Overview

  • Latin America - Q4 2016

Industry Trend And Developments

  • Regional Theme - Q4 2016

Regional Overview

  • Regional Round-up - Q4 2016

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top